Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmatrix (PULM) Common Equity (2016 - 2025)

Pulmatrix's Common Equity history spans 13 years, with the latest figure at $3.8 million for Q4 2025.

  • For Q4 2025, Common Equity fell 57.42% year-over-year to $3.8 million; the TTM value through Dec 2025 reached $3.8 million, down 57.42%, while the annual FY2025 figure was $3.8 million, 57.42% down from the prior year.
  • Common Equity for Q4 2025 was $3.8 million at Pulmatrix, down from $4.7 million in the prior quarter.
  • Across five years, Common Equity topped out at $56.6 million in Q1 2021 and bottomed at $3.8 million in Q4 2025.
  • The 5-year median for Common Equity is $21.7 million (2023), against an average of $25.6 million.
  • The largest annual shift saw Common Equity skyrocketed 716.7% in 2021 before it plummeted 62.42% in 2025.
  • A 5-year view of Common Equity shows it stood at $47.4 million in 2021, then tumbled by 34.44% to $31.1 million in 2022, then crashed by 42.16% to $18.0 million in 2023, then crashed by 50.28% to $8.9 million in 2024, then tumbled by 57.42% to $3.8 million in 2025.
  • Per Business Quant, the three most recent readings for PULM's Common Equity are $3.8 million (Q4 2025), $4.7 million (Q3 2025), and $5.6 million (Q2 2025).